Influenza vaccine production for the U.S. market

Lauren M. Smith; Gigi Kwik Gronvall

doi:10.1089/bsp.2009.0921

Influenza vaccine production for the U.S. market

Research output: Contribution to journal › Article › peer-review

Abstract

Policymakers will be better prepared to formulate and communicate policies for access to influenza vaccine if they understand the vaccine production process and timeline. In addition to providing background, this article highlights where vaccine production delays may occur. This should be useful for describing vaccine production issues that may be raised by the current 2009 H1N1 pandemic.

Original language	English (US)
Pages (from-to)	259-263
Number of pages	5
Journal	Biosecurity and Bioterrorism
Volume	7
Issue number	3
DOIs	https://doi.org/10.1089/bsp.2009.0921
State	Published - Sep 1 2009
Externally published	Yes

ASJC Scopus subject areas

Health(social science)
Public Health, Environmental and Occupational Health
Management, Monitoring, Policy and Law

Access to Document

10.1089/bsp.2009.0921

Fingerprint Dive into the research topics of 'Influenza vaccine production for the U.S. market'. Together they form a unique fingerprint.

Cite this

@article{18a16765542c434aa04502dd3dca21b1,

title = "Influenza vaccine production for the U.S. market",

abstract = "Policymakers will be better prepared to formulate and communicate policies for access to influenza vaccine if they understand the vaccine production process and timeline. In addition to providing background, this article highlights where vaccine production delays may occur. This should be useful for describing vaccine production issues that may be raised by the current 2009 H1N1 pandemic.",

author = "Smith, {Lauren M.} and Gronvall, {Gigi Kwik}",

year = "2009",

month = sep,

day = "1",

doi = "10.1089/bsp.2009.0921",

language = "English (US)",

volume = "7",

pages = "259--263",

journal = "Health security",

issn = "2326-5094",

publisher = "Mary Ann Liebert Inc.",

number = "3",

}

TY - JOUR

T1 - Influenza vaccine production for the U.S. market

AU - Smith, Lauren M.

AU - Gronvall, Gigi Kwik

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Policymakers will be better prepared to formulate and communicate policies for access to influenza vaccine if they understand the vaccine production process and timeline. In addition to providing background, this article highlights where vaccine production delays may occur. This should be useful for describing vaccine production issues that may be raised by the current 2009 H1N1 pandemic.

AB - Policymakers will be better prepared to formulate and communicate policies for access to influenza vaccine if they understand the vaccine production process and timeline. In addition to providing background, this article highlights where vaccine production delays may occur. This should be useful for describing vaccine production issues that may be raised by the current 2009 H1N1 pandemic.

UR - http://www.scopus.com/inward/record.url?scp=70350176279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350176279&partnerID=8YFLogxK

U2 - 10.1089/bsp.2009.0921

DO - 10.1089/bsp.2009.0921

M3 - Article

C2 - 19821749

AN - SCOPUS:70350176279

VL - 7

SP - 259

EP - 263

JO - Health security

JF - Health security

SN - 2326-5094

IS - 3

ER -

Influenza vaccine production for the U.S. market

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this